- 1. Aytaç et al. BJU Int. 1999; 84:50-6.
- 2. Miller T. Am Fam Physician, 2000; 61:95-104.
- 3. Lobb-Rossini K. Journal of Community Nursing Online 1999;13 (10):1-8.
- 4. Mak et al. Eur Urol 2002; 41:132-8.
- 5. Rosen et al. Int. J. of Impotence Research, 2002, 14, 226-244
- 6. Rhoden et al. Int. J. of Impotence Research, 2002, 14, 245-250
- 7. Feldman et al. J Urol 1994;151: 54-61.
- 8. Wespes E. et al. Eur Assoc Urol. 2009. http://www.uroweb.org/fileadmin/tx_eauguidelines/2009/Full/Male_Sexual_Dysf.pdf
- 9. Physical Activity and Public health Guidelines. American College of Sports Medicine.
- 10. Hannan JL et al. J Sex Med .2009 Mar;6 Suppl 3:254-61.
- 11. Jackson G et al. Curr Urol Rep. 2007 Nov;8(6):463-6.
- 12. Kupevian et al. Prev Med. 2010 Jan-Feb;50(1-2):19-25. Epub 2009 Nov 24.
- 13. Dey J et al. Mayo Clin Proc 2002; 77: 276-82.
- 14. IDF Bulletin 2005 http://www.idf.org/idf-worlwide-definition-metabolic-syndrome
- 15. Heidler et al. The journal of Urology, 2007, 177, 651-654
- 16. Metabolic Syndrome. http://www.nhlbi.nih.gov/health/dci/Diseases/ms/ms_erectiele-dysfunctie-behandelingen.html
- 17. Ghezzi A. et al. J. Neurol, 1995 242 (3):123-6.
- 18. Biering – Sorensen
- 19. Solomon H et al. Heart.2003 Mar;89(3):251-3.
- 20. Billups KL et al. Curr Urol Rep. 2005 Nov;6(6):439-44.
- 21. Jackson G et al. J Sex Med 2006; 3:28-36
- 22. http://www.eaasm.eu/Media_centre/News/The_counterfeiting_superhighway
http://v35.pixelcms.com/ams/assets/312296678531/455_EAASM_counterfeiting%20report_020608.pdf
- 23. www.geneesmiddelen-via-internet.be
- 24. Wespes E. et al. BJU International 2007; 99, 121-126
- 25. European Patient Safety and Parallel Pharmaceutical Trade – a potential public health disaster? (November 2007)
http://v35.pixelcms.com/ams/assets/312296678531/Patient_safety_report_FINAL%20VERSION%20p1.pdf
http://v35.pixelcms.com/ams/assets/312296678531/Patient_safety_report_FINAL%20VERSION%20p2.pdf
http://counterfeiting.unicri.it/docs/Sickbusiness%5B1%5D.pdf
